<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD JATS (Z39.96) Journal Publishing DTD v1.4 20241031//EN" "JATS-journalpublishing1-4.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" dtd-version="1.4" xml:lang="en">
  <front>
    <journal-meta>
      <journal-id journal-id-type="publisher-id">ojemd</journal-id>
      <journal-title-group>
        <journal-title>Open Journal of Endocrine and Metabolic Diseases</journal-title>
      </journal-title-group>
      <issn pub-type="epub">2165-7432</issn>
      <issn pub-type="ppub">2165-7424</issn>
      <publisher>
        <publisher-name>Scientific Research Publishing</publisher-name>
      </publisher>
    </journal-meta>
    <article-meta>
      <article-id pub-id-type="doi">10.4236/ojemd.2026.161002</article-id>
      <article-id pub-id-type="publisher-id">ojemd-148818</article-id>
      <article-categories>
        <subj-group>
          <subject>Article</subject>
        </subj-group>
        <subj-group>
          <subject>Medicine</subject>
          <subject>Healthcare</subject>
        </subj-group>
      </article-categories>
      <title-group>
        <article-title>Head Tingling as a Rare Neurological Manifestation of Severe Hypovitaminosis D in an Adolescent: A Case Report</article-title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <contrib-id contrib-id-type="orcid">0009-0006-8743-8516</contrib-id>
          <name name-style="western">
            <surname>Malonga</surname>
            <given-names>Claudine Moma</given-names>
          </name>
          <xref ref-type="aff" rid="aff1">1</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Rodbell</surname>
            <given-names>Kevin</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Nakasone</surname>
            <given-names>Alma</given-names>
          </name>
          <xref ref-type="aff" rid="aff2">2</xref>
        </contrib>
      </contrib-group>
      <aff id="aff1"><label>1</label> Emory University School of Nursing, Atlanta, GA, USA </aff>
      <aff id="aff2"><label>2</label> Sage Hill Pediatrics, Atlanta, GA, USA </aff>
      <author-notes>
        <fn fn-type="conflict" id="fn-conflict">
          <p>The authors declare no conflicts of interest regarding the publication of this paper.</p>
        </fn>
      </author-notes>
      <pub-date pub-type="epub">
        <day>09</day>
        <month>01</month>
        <year>2026</year>
      </pub-date>
      <pub-date pub-type="collection">
        <month>01</month>
        <year>2026</year>
      </pub-date>
      <volume>16</volume>
      <issue>01</issue>
      <fpage>9</fpage>
      <lpage>15</lpage>
      <history>
        <date date-type="received">
          <day>14</day>
          <month>12</month>
          <year>2025</year>
        </date>
        <date date-type="accepted">
          <day>12</day>
          <month>01</month>
          <year>2026</year>
        </date>
        <date date-type="published">
          <day>15</day>
          <month>01</month>
          <year>2026</year>
        </date>
      </history>
      <permissions>
        <copyright-statement>© 2026 by the authors and Scientific Research Publishing Inc.</copyright-statement>
        <copyright-year>2026</copyright-year>
        <license license-type="open-access">
          <license-p> This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license ( <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/licenses/by/4.0/">https://creativecommons.org/licenses/by/4.0/</ext-link> ). </license-p>
        </license>
      </permissions>
      <self-uri content-type="doi" xlink:href="https://doi.org/10.4236/ojemd.2026.161002">https://doi.org/10.4236/ojemd.2026.161002</self-uri>
      <abstract>
        <p>Although Hypovitaminosis D (Vitamin D Deficiency) is commonly known to cause musculoskeletal manifestations, it can also be manifested with unusual symptoms, making the diagnosis challenging, especially in adolescents without the obvious risk factor of obesity. This article presents a case report with an atypical neurological manifestation, head tingling, that illustrates how evasive the diagnosis of hypovitaminosis D can be, especially in an adolescent with low-normal weight, as it is often overlooked in non-obese individuals. This case highlights a potential direct neurologic manifestation of severe hypovitaminosis D in adolescents with normal calcium levels, expanding the clinical spectrum of vitamin D deficiency. The report summarizes the unusual presenting symptoms, the response to vitamin D supplementation, and the recommendations for pediatric clinicians with regard to the current guidelines.</p>
      </abstract>
      <kwd-group kwd-group-type="author-generated" xml:lang="en">
        <kwd>Hypovitaminosis D</kwd>
        <kwd>Vitamin D Deficiency</kwd>
        <kwd>Adolescents</kwd>
        <kwd>Head Tingling</kwd>
        <kwd>Pediatric-Case Report</kwd>
      </kwd-group>
    </article-meta>
  </front>
  <body>
    <sec id="sec1">
      <title>1. Introduction</title>
      <p>Hypovitaminosis D in adolescents has become endemic and often goes unnoticed due to the absence of classic symptoms such as osteomalacia. There is no universally accepted normal vitamin D level; however, some authorities define deficiency as a serum 25-hydroxyvitamin D [25(OH)D] level &lt; 12 ng/mL (&lt;30 nmol/L) and insufficiency as 12 - &lt;20 ng/mL (30 - &lt;50 nmol/L) [<xref ref-type="bibr" rid="B1">1</xref>]. Due to lack of consensus, other authorities and laboratories still consider levels of 20 - 29 ng/mL (50 - 74 nmol/L) as insufficient [<xref ref-type="bibr" rid="B2">2</xref>][<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Hypovitaminosis D is more prevalent among adolescents with excess weight, darker skin, limited sunlight exposure, restricted diets, or malabsorption disorders, but it is often overlooked in non-obese individuals [<xref ref-type="bibr" rid="B1">1</xref>]. Though more common in older adults, its incidence in adolescents is rising, partly due to decreased outdoor activity and increased nutritional demands during growth and puberty [<xref ref-type="bibr" rid="B2">2</xref>][<xref ref-type="bibr" rid="B4">4</xref>].</p>
      <p>Common symptoms include musculoskeletal complaints; however, atypical neurological symptoms such as acral paresthesia have also been documented [<xref ref-type="bibr" rid="B5">5</xref>]. To our knowledge, head tingling has not previously been associated with vitamin D deficiency alone, independent of hypocalcemia. Common causes of head or scalp tingling include neurologic, metabolic, infectious, inflammatory, and psychiatric conditions, as well as deficiencies in vitamins B1, B6, B12, and E [<xref ref-type="bibr" rid="B1">1</xref>][<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>This report presents a rare case of severe vitamin D deficiency manifesting primarily as head tingling, sometimes accompanied by extremity tingling, in an adolescent male.</p>
    </sec>
    <sec id="sec2">
      <title>2. Case Presentation</title>
      <sec id="sec2dot1">
        <title>2.1. Chief Complaint and History of Present Illness</title>
        <p>A 14-year-old African American male, previously healthy, presented with a three-week history of daily diffuse head tingling. Episodes were intermittent, lasting several seconds, and sometimes associated with hand and foot tingling. There were no known triggers. He denied muscle cramps, pain, numbness, headaches, dizziness, fatigue, scalp changes, mood or vision disturbances, or other neurological symptoms.</p>
      </sec>
      <sec id="sec2dot2">
        <title>2.2. Medical, Family, and Social History</title>
        <p>Past medical history included mild scoliosis and a remote hand fracture. He had no history of hospitalizations or medication use. Family history was non-contributory, with no history of diabetes or malabsorption. Social history revealed recent academic stress due to transitioning to a competitive school. He reported 6 - 7 hours of sleep per night, denied substance use, and consumed a typical American diet.</p>
      </sec>
      <sec id="sec2dot3">
        <title>2.3. Physical Examination</title>
        <p>Comprehensive neurological and musculoskeletal examination was unremarkable, aside from mild scoliosis. He had normal cranial nerve function, strength, sensation, reflexes, coordination, and gait. BMI was 16.8 (8th percentile). No scalp abnormalities were noted.</p>
      </sec>
      <sec id="sec2dot4">
        <title>2.4. Differential Diagnosis</title>
        <p>The initial diagnosis was considered a stress-related disturbance. However, a broad differential was explored, including metabolic disorders (e.g., diabetes, hypothyroidism), neurological diseases (e.g., migraines, multiple sclerosis, epilepsy), nutritional deficiencies (B vitamins, vitamin E, folate), autoimmune diseases (e.g., lupus, fibromyalgia), toxins, infections (Lyme disease, shingles), and congenital neuropathies [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B8">8</xref>]. All these pathologies were ruled out through thorough history, physical examination, and laboratory studies.</p>
      </sec>
      <sec id="sec2dot5">
        <title>2.5. Diagnostic Evaluation</title>
        <p>Laboratory studies are summarized in <bold>Tables 1</bold><bold>-</bold><bold>3</bold>. Initial workup demonstrated a normal complete blood count and comprehensive metabolic panel, including normal calcium, vitamin B12, and glucose levels (<bold>Table 1</bold> and <bold>Table 2</bold>). Hemoglobin A1c (5.4%) and thyroid-stimulating hormone levels were also within the normal range (<bold>Table 3</bold>). Serum 25(OH)D was markedly low at 5.6 ng/mL (reference range: 30 - 100 ng/mL), leading to a diagnosis of hypovitaminosis D. Linking head tingling to hypovitaminosis D itself in the absence of hypocalcemia was quite debatable; nevertheless, decision was made to attempt a trial of vitamin D supplementation to investigate any direct causal relation.</p>
        <p><bold>Table 1.</bold> Complete blood count with differential.</p>
        <table-wrap id="tbl1">
          <label>Table 1</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Parameter/UOM</bold>
                </td>
                <td>
                  <bold>Result</bold>
                </td>
                <td>
                  <bold>Reference Range</bold>
                </td>
              </tr>
              <tr>
                <td>
                  WBC (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>7.1</td>
                <td>3.4 - 10.8</td>
              </tr>
              <tr>
                <td>
                  RBC (×10
                  <sup>6</sup>
                  /µL)
                </td>
                <td>4.74</td>
                <td>4.14 - 5.80</td>
              </tr>
              <tr>
                <td>Hemoglobin (g/dL)</td>
                <td>14.3</td>
                <td>12.6 - 17.7</td>
              </tr>
              <tr>
                <td>Hematocrit (%)</td>
                <td>42.9</td>
                <td>37.5 - 51.0</td>
              </tr>
              <tr>
                <td>MCV (fL)</td>
                <td>91</td>
                <td>79 - 97</td>
              </tr>
              <tr>
                <td>MCH (pg)</td>
                <td>30.2</td>
                <td>26.6 - 33.0</td>
              </tr>
              <tr>
                <td>MCHC (g/dL)</td>
                <td>33.3</td>
                <td>31.5 - 35.7</td>
              </tr>
              <tr>
                <td>RDW (%)</td>
                <td>12.3</td>
                <td>11.6 - 15.4</td>
              </tr>
              <tr>
                <td>
                  Platelets (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>311</td>
                <td>150 - 450</td>
              </tr>
              <tr>
                <td>Neutrophils (%)</td>
                <td>44</td>
                <td>Not established</td>
              </tr>
              <tr>
                <td>Lymphocytes (%)</td>
                <td>43</td>
                <td>Not established</td>
              </tr>
              <tr>
                <td>Monocytes (%)</td>
                <td>9</td>
                <td>Not established</td>
              </tr>
              <tr>
                <td>Eosinophils (%)</td>
                <td>3</td>
                <td>Not established</td>
              </tr>
              <tr>
                <td>Basophils (%)</td>
                <td>1</td>
                <td>Not established</td>
              </tr>
              <tr>
                <td>
                  Neutrophils, absolute (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>3.1</td>
                <td>1.4 - 7.0</td>
              </tr>
              <tr>
                <td>
                  Lymphocytes, absolute (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>3.1</td>
                <td>0.7 - 3.1</td>
              </tr>
              <tr>
                <td>
                  Monocytes, absolute (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>0.6</td>
                <td>0.1 - 0.9</td>
              </tr>
              <tr>
                <td>
                  Eosinophils, absolute (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>0.2</td>
                <td>0.0 - 0.4</td>
              </tr>
              <tr>
                <td>
                  Basophils, absolute (×10
                  <sup>3</sup>
                  /µL)
                </td>
                <td>0.1</td>
                <td>0.0 - 0.3</td>
              </tr>
              <tr>
                <td>Immature granulocytes (%)</td>
                <td>0</td>
                <td>Not established</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>Abbreviations: UOM = unit of measure WBC = white blood cell count; RBC = red blood cell count; MCV = mean corpuscular volume; MCH = mean corpuscular hemoglobin; MCHC = mean corpuscular hemoglobin concentration; RDW = red cell distribution width.</p>
        <p><bold>Table 2.</bold> Metabolic and nutritional laboratory evaluation.</p>
        <table-wrap id="tbl2">
          <label>Table 2</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Test</bold>
                </td>
                <td>
                  <bold>Result</bold>
                </td>
                <td>
                  <bold>Units</bold>
                </td>
                <td>
                  <bold>Reference Range</bold>
                </td>
              </tr>
              <tr>
                <td>Glucose</td>
                <td>71</td>
                <td>mg/dL</td>
                <td>70 - 99</td>
              </tr>
              <tr>
                <td>BUN</td>
                <td>8</td>
                <td>mg/dL</td>
                <td>5 - 18</td>
              </tr>
              <tr>
                <td>Creatinine</td>
                <td>0.49</td>
                <td>mg/dL</td>
                <td>0.49 - 0.90</td>
              </tr>
              <tr>
                <td>Sodium</td>
                <td>139</td>
                <td>mmol/L</td>
                <td>134 - 144</td>
              </tr>
              <tr>
                <td>Potassium</td>
                <td>4.0</td>
                <td>mmol/L</td>
                <td>3.5 - 5.2</td>
              </tr>
              <tr>
                <td>Chloride</td>
                <td>102</td>
                <td>mmol/L</td>
                <td>96 - 106</td>
              </tr>
              <tr>
                <td>Carbon dioxide (total)</td>
                <td>17 ↓</td>
                <td>mmol/L</td>
                <td>20 - 29</td>
              </tr>
              <tr>
                <td>Calcium</td>
                <td>9.7</td>
                <td>mg/dL</td>
                <td>8.9 - 10.4</td>
              </tr>
              <tr>
                <td>Total protein</td>
                <td>7.6</td>
                <td>g/dL</td>
                <td>6.0 - 8.5</td>
              </tr>
              <tr>
                <td>Albumin</td>
                <td>5.1</td>
                <td>g/dL</td>
                <td>4.3 - 5.2</td>
              </tr>
              <tr>
                <td>Total bilirubin</td>
                <td>1.0</td>
                <td>mg/dL</td>
                <td>0.0 - 1.2</td>
              </tr>
              <tr>
                <td>Alkaline phosphatase</td>
                <td>269</td>
                <td>IU/L</td>
                <td>114 - 375</td>
              </tr>
              <tr>
                <td>AST</td>
                <td>22</td>
                <td>IU/L</td>
                <td>0 - 40</td>
              </tr>
              <tr>
                <td>ALT</td>
                <td>14</td>
                <td>IU/L</td>
                <td>0 - 30</td>
              </tr>
              <tr>
                <td>Vitamin B12</td>
                <td>289</td>
                <td>pg/mL</td>
                <td>232 - 1245</td>
              </tr>
              <tr>
                <td>Folate (serum)</td>
                <td>12.8</td>
                <td>ng/mL</td>
                <td>&gt;3.0</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p><bold>Table 3.</bold> Endocrine and glycemic markers.</p>
        <table-wrap id="tbl3">
          <label>Table 3</label>
          <table>
            <tbody>
              <tr>
                <td>
                  <bold>Test</bold>
                </td>
                <td>
                  <bold>Result</bold>
                </td>
                <td>
                  <bold>Reference Range</bold>
                </td>
              </tr>
              <tr>
                <td>Hemoglobin A1c (%)</td>
                <td>5.4</td>
                <td>4.8 - 5.6</td>
              </tr>
              <tr>
                <td>TSH (µIU/mL)</td>
                <td>2.810</td>
                <td>0.450 - 4.500</td>
              </tr>
              <tr>
                <td>Vitamin D, 25-hydroxy (ng/mL)</td>
                <td>5.6 ↓</td>
                <td>30.0 - 100.0</td>
              </tr>
            </tbody>
          </table>
        </table-wrap>
        <p>↓ indicates value below reference range.</p>
      </sec>
      <sec id="sec2dot6">
        <title>2.6. Management and Outcome</title>
        <p>The patient was started on vitamin D supplementation at 50,000 IU weekly for 8 weeks. The level of serum 25(OH)D increased to 20 ng/mL, with marked symptoms’ improvement (tingling was very rare). After 4 more weeks of the same dosage, due to occasional symptoms, his vitamin D level increased to 39 and symptoms completely resolved. Education regarding modifiable risk factors, dietary intake (recommended dietary allowance for vitamin D: 400 - 600 IU), and sunlight exposure was provided for optimal level maintenance [<xref ref-type="bibr" rid="B1">1</xref>].</p>
      </sec>
    </sec>
    <sec id="sec3">
      <title>3. Pathophysiology</title>
      <p>Vitamin D, particularly in its active form calcitriol [1,25(OH)<sub>2</sub>D], is now recognized as a neurosteroid hormone involved in neurodevelopment, neurotransmission, and neuroprotection [<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B8">8</xref>]. Vitamin D deficiency may disrupt neuronal excitability through altered calcium and chloride channel regulation, leading to peripheral neuropathy and central sensitization [<xref ref-type="bibr" rid="B5">5</xref>][<xref ref-type="bibr" rid="B7">7</xref>][<xref ref-type="bibr" rid="B8">8</xref>].</p>
      <p>Vitamin D receptors are widely expressed in peripheral and central neural tissue, where vitamin D regulates neurotrophic factors such as nerve growth factor [<xref ref-type="bibr" rid="B9">9</xref>]. Deficiency may impair neuronal survival, growth, and repair, contributing to neuropathic symptoms, including tingling, via direct neuronal excitability or altered sensory processing [<xref ref-type="bibr" rid="B9">9</xref>][<xref ref-type="bibr" rid="B10">10</xref>]. Vitamin D also modulates inflammatory cytokines, and deficiency may promote neuroinflammation and worsen neuropathic symptoms [<xref ref-type="bibr" rid="B10">10</xref>][<xref ref-type="bibr" rid="B11">11</xref>]. Recent clinical guidelines recognize vitamin D deficiency’s wider implications, including neuromuscular symptoms like muscle weakness and pain that may indirectly contribute to neurologic complaints such as tingling [<xref ref-type="bibr" rid="B11">11</xref>].</p>
    </sec>
    <sec id="sec4">
      <title>4. Discussion</title>
      <p>This case highlights a rare presentation of severe hypovitaminosis D with normal serum calcium manifesting as head tingling in an adolescent, with complete resolution following vitamin D supplementation. While acral paresthesia and other neurological symptoms have been reported in vitamin D deficiency, head tingling in the absence of hypocalcemia has not been previously described [<xref ref-type="bibr" rid="B5">5</xref>][<xref ref-type="bibr" rid="B12">12</xref>]-[<xref ref-type="bibr" rid="B14">14</xref>]. Other potential tingling causes were thoroughly excluded through clinical evaluation and laboratory testing [<xref ref-type="bibr" rid="B1">1</xref>][<xref ref-type="bibr" rid="B6">6</xref>].</p>
      <p>Unlike prior reports linking paresthesia to hypocalcemia in vitamin D deficiency [<xref ref-type="bibr" rid="B4">4</xref>][<xref ref-type="bibr" rid="B15">15</xref>], this patient had normal calcium levels, suggesting a direct neurologic effect of vitamin D deficiency. Previous clinical guidelines and trials have reported resolution of paresthesia after correcting vitamin D deficiency with calcium repletion, suggesting a causal role for calcium in those cases [<xref ref-type="bibr" rid="B11">11</xref>]. The absence of electrolyte abnormalities, including normal serum calcium, strengthens the hypothesis that vitamin D deficiency itself may contribute to neurologic symptoms rather than acting solely through secondary hypocalcemia. This observation broadens the clinical understanding of hypovitaminosis D and suggests that neurologic symptoms may be an underrecognized manifestation in adolescents.</p>
      <p>Additionally, this case supports evidence that serum vitamin D levels below 30 ng/mL may not be optimal, as complete symptom resolution occurred only after levels exceeded this threshold [<xref ref-type="bibr" rid="B2">2</xref>][<xref ref-type="bibr" rid="B3">3</xref>].</p>
      <p>Limitations include inherent constraints of a single-case report, which preclude definitive causal inference. While the temporal relationship between supplementation and symptom resolution is strong, it does not definitively prove causation, and a coincidental recovery cannot be entirely excluded. This case study did not extend beyond the maintenance phase to ensure that tingling did not recur. Further prolonged studies are needed to reinforce the direct correlation between vitamin D deficiency without hypocalcemia and head tingling.</p>
    </sec>
    <sec id="sec5">
      <title>5. Conclusion</title>
      <p>Severe hypovitaminosis D may present with atypical neurological symptoms, including head tingling. The case highlights a direct neurologic effect of vitamin D deficiency rather than an effect of secondary hypocalcemia. It supports consideration of targeted vitamin D evaluation in adolescents presenting with unexplained sensory symptoms or known risk factors. Pediatric clinicians should consider vitamin D deficiency in the differential for unexplained paresthesia and aim at optimal levels above 30 ng/dL when supplementing vitamin D. Screening symptomatic or high-risk adolescents should be emphasized in pediatric practice, regardless of obesity or overweight status.</p>
    </sec>
    <sec id="sec6">
      <title>Acknowledgements</title>
      <p>No funding or sponsorship was received for the publication of this case report. The authors would like to gratefully acknowledge the patient and his mother for their cooperation and agreement to publish this case.</p>
    </sec>
    <sec id="sec7">
      <title>Ethical Statement</title>
      <p>Written informed consent was obtained from the patient’s parent for publication of this case report and any accompanying results. </p>
    </sec>
  </body>
  <back>
    <ref-list>
      <title>References</title>
      <ref id="B1">
        <label>1.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">National Institutes of Health (2025) Vitamin D-Fact Sheet for Health Professionals. NIH Office of Dietary Supplements. https://ods.od.nih.gov/factsheets/VitaminD-HealthProfessional/</mixed-citation>
          <element-citation publication-type="web">
            <year>2025</year>
            <article-title>Vitamin D-Fact Sheet for Health Professionals</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B2">
        <label>2.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Corsello, A., Spolidoro, G.C.I., Milani, G.P. and Agostoni, C. (2023) Vitamin D in Pediatric Age: Current Evidence, Recommendations, and Misunderstandings. <italic>Frontiers in Medicine</italic>, 10, Article 1107855. https://doi.org/10.3389/fmed.2023.1107855 <pub-id pub-id-type="doi">10.3389/fmed.2023.1107855</pub-id><pub-id pub-id-type="pmid">37007781</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3389/fmed.2023.1107855">https://doi.org/10.3389/fmed.2023.1107855</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Corsello, A.</string-name>
              <string-name>Spolidoro, G.C.I.</string-name>
              <string-name>Milani, G.P.</string-name>
              <string-name>Agostoni, C.</string-name>
              <string-name>Evidence, R</string-name>
            </person-group>
            <year>2023</year>
            <article-title>Vitamin D in Pediatric Age: Current Evidence, Recommendations, and Misunderstandings</article-title>
            <source>Frontiers in Medicine</source>
            <volume>10</volume>
            <elocation-id>1107855</elocation-id>
            <pub-id pub-id-type="doi">10.3389/fmed.2023.1107855</pub-id>
            <pub-id pub-id-type="pmid">37007781</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B3">
        <label>3.</label>
        <citation-alternatives>
          <mixed-citation publication-type="web">Carpenter, T., Jastreboff, A. and Haims, A. (2023) Vitamin D Deficiency. Yale Medicine. https://www.yalemedicine.org/conditions/vitamin-d-deficiency</mixed-citation>
          <element-citation publication-type="web">
            <person-group person-group-type="author">
              <string-name>Carpenter, T.</string-name>
              <string-name>Jastreboff, A.</string-name>
              <string-name>Haims, A.</string-name>
            </person-group>
            <year>2023</year>
            <article-title>Vitamin D Deficiency</article-title>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B4">
        <label>4.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Rothstein, R. and Allen, N. (2021) Severe Hypocalcemia and Vitamin D Deficiency in Adolescence—A Case Series. <italic>Journal of the Endocrine Society</italic>, 5, A220. https://doi.org/10.1210/jendso/bvab048.447 <pub-id pub-id-type="doi">10.1210/jendso/bvab048.447</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/jendso/bvab048.447">https://doi.org/10.1210/jendso/bvab048.447</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Rothstein, R.</string-name>
              <string-name>Allen, N.</string-name>
            </person-group>
            <year>2021</year>
            <article-title>Severe Hypocalcemia and Vitamin D Deficiency in Adolescence—A Case Series</article-title>
            <source>Journal of the Endocrine Society</source>
            <volume>5</volume>
            <pub-id pub-id-type="doi">10.1210/jendso/bvab048.447</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B5">
        <label>5.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Luo, J.J., Bumanlag, F. and Dun, N.J. (2019) Patients with Sensory Symptoms of Acral Paresthesia: Routine Laboratory Findings in Neuromuscular Consultation. <italic>Journal of Neurology and Experimental Neuroscience</italic>, 5, 52-55. https://doi.org/10.17756/jnen.2019-053 <pub-id pub-id-type="doi">10.17756/jnen.2019-053</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.17756/jnen.2019-053">https://doi.org/10.17756/jnen.2019-053</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Luo, J.J.</string-name>
              <string-name>Bumanlag, F.</string-name>
              <string-name>Dun, N.J.</string-name>
            </person-group>
            <year>2019</year>
            <article-title>Patients with Sensory Symptoms of Acral Paresthesia: Routine Laboratory Findings in Neuromuscular Consultation</article-title>
            <source>Journal of Neurology and Experimental Neuroscience</source>
            <volume>5</volume>
            <pub-id pub-id-type="doi">10.17756/jnen.2019-053</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B6">
        <label>6.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Ju, T., Vander Does, A. and Yosipovitch, G. (2022) Scalp Dysesthesia: A Neuropathic Phenomenon. <italic>Journal of the European Academy of Dermatology and Venereology</italic>, 36, 790-796. https://doi.org/10.1111/jdv.17985 <pub-id pub-id-type="doi">10.1111/jdv.17985</pub-id><pub-id pub-id-type="pmid">35122352</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/jdv.17985">https://doi.org/10.1111/jdv.17985</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Ju, T.</string-name>
              <string-name>Does, A.</string-name>
              <string-name>Yosipovitch, G.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Scalp Dysesthesia: A Neuropathic Phenomenon</article-title>
            <source>Journal of the European Academy of Dermatology and Venereology</source>
            <volume>36</volume>
            <pub-id pub-id-type="doi">10.1111/jdv.17985</pub-id>
            <pub-id pub-id-type="pmid">35122352</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B7">
        <label>7.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Shi, Y., Shi, Y., Jie, R., He, J., Luo, Z. and Li, J. (2024) Vitamin D: The Crucial Neuroprotective Factor for Nerve Cells. <italic>Neuroscience</italic>, 560, 272-285. https://doi.org/10.1016/j.neuroscience.2024.09.042 <pub-id pub-id-type="doi">10.1016/j.neuroscience.2024.09.042</pub-id><pub-id pub-id-type="pmid">39343160</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.neuroscience.2024.09.042">https://doi.org/10.1016/j.neuroscience.2024.09.042</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Shi, Y.</string-name>
              <string-name>Shi, Y.</string-name>
              <string-name>Jie, R.</string-name>
              <string-name>He, J.</string-name>
              <string-name>Luo, Z.</string-name>
              <string-name>Li, J.</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Vitamin D: The Crucial Neuroprotective Factor for Nerve Cells</article-title>
            <source>Neuroscience</source>
            <volume>560</volume>
            <pub-id pub-id-type="doi">10.1016/j.neuroscience.2024.09.042</pub-id>
            <pub-id pub-id-type="pmid">39343160</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B8">
        <label>8.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Sailike, B., Onzhanova, Z., Akbay, B., Tokay, T. and Molnár, F. (2024) Vitamin D in Central Nervous System: Implications for Neurological Disorders. <italic>International</italic><italic>Jour</italic><italic>nal of Molecular Sciences</italic>, 25, Article No. 7809. https://doi.org/10.3390/ijms25147809 <pub-id pub-id-type="doi">10.3390/ijms25147809</pub-id><pub-id pub-id-type="pmid">39063051</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.3390/ijms25147809">https://doi.org/10.3390/ijms25147809</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Sailike, B.</string-name>
              <string-name>Onzhanova, Z.</string-name>
              <string-name>Akbay, B.</string-name>
              <string-name>Tokay, T.</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Vitamin D in Central Nervous System: Implications for Neurological Disorders</article-title>
            <source>International Journal of Molecular Sciences</source>
            <volume>25</volume>
            <elocation-id>No</elocation-id>
            <pub-id pub-id-type="doi">10.3390/ijms25147809</pub-id>
            <pub-id pub-id-type="pmid">39063051</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B9">
        <label>9.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Alam, U., Arul-Devah, V., Javed, S. and Malik, R.A. (2016) Vitamin D and Diabetic Complications: True or False Prophet? <italic>Diabetes Therapy</italic>, 7, 11-26. https://doi.org/10.1007/s13300-016-0159-x <pub-id pub-id-type="doi">10.1007/s13300-016-0159-x</pub-id><pub-id pub-id-type="pmid">26971351</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s13300-016-0159-x">https://doi.org/10.1007/s13300-016-0159-x</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Alam, U.</string-name>
              <string-name>Arul-Devah, V.</string-name>
              <string-name>Javed, S.</string-name>
              <string-name>Malik, R.A.</string-name>
            </person-group>
            <year>2016</year>
            <article-title>Vitamin D and Diabetic Complications: True or False Prophet? Diabetes Therapy, 7, 11-26</article-title>
            <pub-id pub-id-type="doi">10.1007/s13300-016-0159-x</pub-id>
            <pub-id pub-id-type="pmid">26971351</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B10">
        <label>10.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Gilbody, A. and Gilbody, J. (2025) Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials. <italic>Endocrinology</italic>, <italic>Diabetes &amp; Metabolism</italic>, 8, e70118. https://doi.org/10.1002/edm2.70118 <pub-id pub-id-type="doi">10.1002/edm2.70118</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/edm2.70118">https://doi.org/10.1002/edm2.70118</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Gilbody, A.</string-name>
              <string-name>Gilbody, J.</string-name>
              <string-name>Endocrinology, D</string-name>
            </person-group>
            <year>2025</year>
            <article-title>Vitamin D for Painful Diabetic Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials</article-title>
            <source>Endocrinology</source>
            <volume>8</volume>
            <pub-id pub-id-type="doi">10.1002/edm2.70118</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B11">
        <label>11.</label>
        <citation-alternatives>
          <mixed-citation publication-type="journal">Demay, M.B., Pittas, A.G., Bikle, D.D., Diab, D.L., Kiely, M.E., Lazaretti-Castro, M., <italic>et al</italic>. (2024) Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline. <italic>The Journal of Clinical Endocrinology &amp; Metabolism</italic>, 109, 1907-1947. https://doi.org/10.1210/clinem/dgae290 <pub-id pub-id-type="doi">10.1210/clinem/dgae290</pub-id><pub-id pub-id-type="pmid">38828931</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1210/clinem/dgae290">https://doi.org/10.1210/clinem/dgae290</ext-link></mixed-citation>
          <element-citation publication-type="journal">
            <person-group person-group-type="author">
              <string-name>Demay, M.B.</string-name>
              <string-name>Pittas, A.G.</string-name>
              <string-name>Bikle, D.D.</string-name>
              <string-name>Diab, D.L.</string-name>
              <string-name>Kiely, M.E.</string-name>
              <string-name>Lazaretti-Castro, M.</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Vitamin D for the Prevention of Disease: An Endocrine Society Clinical Practice Guideline</article-title>
            <source>The Journal of Clinical Endocrinology &amp; Metabolism</source>
            <volume>109</volume>
            <pub-id pub-id-type="doi">10.1210/clinem/dgae290</pub-id>
            <pub-id pub-id-type="pmid">38828931</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B12">
        <label>12.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Zhang, W., Yu, S., Jiao, B., <italic>et al</italic>. (2024) Vitamin D3 Attenuates Neuropathic Pain via Suppression of Ferroptosis. <italic>CNS Neuroscience &amp; Therapeutics</italic>, 30, e70067.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Zhang, W.</string-name>
              <string-name>Yu, S.</string-name>
              <string-name>Jiao, B.</string-name>
            </person-group>
            <year>2024</year>
            <article-title>Vitamin D3 Attenuates Neuropathic Pain via Suppression of Ferroptosis</article-title>
            <source>CNS Neuroscience &amp; Therapeutics</source>
            <volume>30</volume>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B13">
        <label>13.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Fouchard, M., Brenaut, E., Genestet, S., <italic>et al</italic>. (2022) Small-Fiber Neuropathies and Vitamin D Deficiency. <italic>Frontiers in Medicine</italic>, 9, Article 1051967.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Fouchard, M.</string-name>
              <string-name>Brenaut, E.</string-name>
              <string-name>Genestet, S.</string-name>
            </person-group>
            <year>2022</year>
            <article-title>Small-Fiber Neuropathies and Vitamin D Deficiency</article-title>
            <source>Frontiers in Medicine</source>
            <volume>9</volume>
            <elocation-id>1051967</elocation-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B14">
        <label>14.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Korkut, O. and Aydin, H. (2023) Neurological Symptoms in Children and Adolescents with Vitamin D Deficiency. <italic>Children</italic> ( <italic>Basel</italic>), 10, Article No. 1251.</mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Korkut, O.</string-name>
              <string-name>Aydin, H.</string-name>
            </person-group>
            <year>2023</year>
            <article-title>Neurological Symptoms in Children and Adolescents with Vitamin D Deficiency</article-title>
            <source>Children (Basel)</source>
            <volume>10</volume>
            <elocation-id>No</elocation-id>
          </element-citation>
        </citation-alternatives>
      </ref>
      <ref id="B15">
        <label>15.</label>
        <citation-alternatives>
          <mixed-citation publication-type="other">Singh, A., Kaur, R., Dass, B. and Ejaz, A. (2020) Tingles, Tetany, and Electrolyte Derangements. <italic>Cureus</italic>, 12, e7854. https://doi.org/10.7759/cureus.7854 <pub-id pub-id-type="doi">10.7759/cureus.7854</pub-id><pub-id pub-id-type="pmid">32483505</pub-id><ext-link ext-link-type="uri" xlink:href="https://doi.org/10.7759/cureus.7854">https://doi.org/10.7759/cureus.7854</ext-link></mixed-citation>
          <element-citation publication-type="other">
            <person-group person-group-type="author">
              <string-name>Singh, A.</string-name>
              <string-name>Kaur, R.</string-name>
              <string-name>Dass, B.</string-name>
              <string-name>Ejaz, A.</string-name>
              <string-name>Tingles, T</string-name>
            </person-group>
            <year>2020</year>
            <article-title>Tingles, Tetany, and Electrolyte Derangements</article-title>
            <source>Cureus</source>
            <volume>12</volume>
            <pub-id pub-id-type="doi">10.7759/cureus.7854</pub-id>
            <pub-id pub-id-type="pmid">32483505</pub-id>
          </element-citation>
        </citation-alternatives>
      </ref>
    </ref-list>
  </back>
</article>